These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1285464)

  • 1. [Postmenopausal osteoporosis from the viewpoint of the gynecologist].
    Dören M; Schneider HP
    Z Gesamte Inn Med; 1992 Dec; 47(12):568-72. PubMed ID: 1285464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of osteoporosis by the gynecologist].
    Schneider HP; Dören M
    Zentralbl Gynakol; 1994; 116(12):691-4. PubMed ID: 7846982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoporosis: new hope for the future.
    Masi L; Bilezikian JP
    Int J Fertil Womens Med; 1997; 42(4):245-54. PubMed ID: 9309458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Estrogen substitution in the postmenopause--effect and compliance].
    Dören M
    Ther Umsch; 1994 Nov; 51(11):767-72. PubMed ID: 7839335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Osteoporosis from the gynecologic viewpoint].
    Schneider HP; Dören M
    Zentralbl Gynakol; 1992; 114(7):333-50. PubMed ID: 1509831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen-progestogen replacement therapy in postmenopausal women--is 1 mg estradiolvalerate sufficient to maintain axial trabecular bone density?
    Dören M; Schneider HP
    Int J Clin Pharmacol Ther; 1994 May; 32(5):254-8. PubMed ID: 7921520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Some problems of postmenopausal osteoporosis prevention with hormone replacement therapy].
    Liu JL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Jun; 25(3):240-3. PubMed ID: 12905731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study on two different dosages of conjugated equine estrogen continuously combined with medroxyprogesterone in prevention of postmenopausal osteoporosis].
    Wu Y; Liu J; Xing S; Xu R; Zhang Z; Wang Y
    Zhonghua Fu Chan Ke Za Zhi; 2002 May; 37(5):267-70. PubMed ID: 12133397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A
    Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and treatment of osteoporosis with hormone replacement therapy.
    Christiansen C
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 1():45-54. PubMed ID: 8499959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen therapy in postmenopausal osteoporosis. What we know and what we don't.
    Roux C
    Rev Rhum Engl Ed; 1997 Jun; 64(6):402-9. PubMed ID: 9513613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing the dose of hormone replacement therapy.
    Rice VM
    Int J Fertil Womens Med; 2002; 47(5):205-10. PubMed ID: 12469707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoporosis: preventive strategies.
    Kulak CA; Bilezikian JP
    Int J Fertil Womens Med; 1998; 43(2):56-64. PubMed ID: 9609204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and treatment of postmenopausal women at risk for the development of osteoporosis.
    Dören M; Schneider HP
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):431-3. PubMed ID: 1490769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogens in prevention and treatment of osteoporosis.
    Lindsay R
    Schweiz Med Wochenschr; 1989 Dec; 119(50):1806-10. PubMed ID: 2532784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
    Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmenopausal osteoporosis and hormone replacement therapy.
    Gambacciani M; Vacca F
    Minerva Med; 2004 Dec; 95(6):507-20. PubMed ID: 15785435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
    Josse RG
    CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term estrogen and hormone replacement therapy for the prevention and treatment of osteoporosis.
    Levine JP
    Curr Womens Health Rep; 2003 Jun; 3(3):181-6. PubMed ID: 12734027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Estrogen treatment for prevention and therapy of osteoporosis].
    von Werder K
    Fortschr Med; 1997 Oct; 115(29):44-9. PubMed ID: 9445834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.